Maxim Foundation
Since its founding, Maxim Group recognized its obligation to be a socially responsible organization. In 2002, the Executive Committee established the Maxim Foundation to meet that obligation. The Foundation has contributed to worthy causes at home and abroad such as the National Multiple Sclerosis Society, the American Cancer Society, The Leukemia & Lymphoma Society, The Brain Tumor Foundation and The Red Cross. In addition the Foundation has contributed to relief efforts such as the December 2004 Asian Tsunami; Hurricane Katrina, which struck New Orleans and the Mississippi Gulf Coast in August, 2005; the January 2010 earthquake in Haiti; and in 2012, Hurricane Sandy, which affected communities in New York, New Jersey and Connecticut.
The Foundation’s focus was expanded in 2004 to include assistance for local families that were caring for children with special healthcare needs. Many of these children are medically fragile, chronically ill or living with life-threatening illnesses.
to help obtain supportive services and improve the quality of life for the children and their families. In 2010, the firm established the Maxim Group G.O.A.L. (Giving Opportunities of A Lifetime) Program. The G.O.A.L. Program is designed to provide underprivileged children, and children undergoing difficult medical treatment living in the greater New York City area, with an incredible experience that enriches the lives of the child and their families. The G.O.A.L. experience is often more than a dream come true: It’s the catalyst that rekindles their belief in themselves and the promise of a better future. The road to a meaningful G.O.A.L. experience starts when a caring person refers a child to the foundation.
Maxim Group is especially grateful to its employees, sponsors, donors and volunteers whose time and support have truly enabled the Maxim Charitable Foundation to make a difference in the lives of those less fortunate.
Latest Maxim Group News
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced
Lexaria Announces Pricing of $1.6 Million Registered Direct Offering
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms,
Safe & Green Holdings Corp. Completes Spin-Off of Safe and Green Development Corporation
Safe & Green Holdings Corp. (NASDAQ: SGBX) (“SG Holdings” or the “Company”), a leading developer,